Concomitant use may lower systemic exposures and reduce effectiveness of SOLIRIS. Closely monitor for reduced effectiveness.
Source: NLP:eculizumab
Neonatal Fc Receptor Blockers Interactions
2 interactions on record
Concomitant use may lower systemic eculizumab exposures and reduce effectiveness; close monitoring required.
Source: NLP:eculizumab-aeeb